Omnicell Inc

OMCLNASDAQ · USD
33.69USD-0.18 (-0.54%)
897

Omnicell Inc (OMCL) Covered Calls

As of September 28, 2026, OMCL has 9 covered call opportunities in the coming three months. Return ranges from 8.4 to 63.7% until expiration. Annualized return ranges from 23.4 to 415.2%. The nearest expiration is November 20, 2026. Maximum potential profit is $2,144.

Read more

Running OMCL covered calls helps you generate consistent income from Omnicell Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Omnicell Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best OMCL covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if OMCL stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling OMCL covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Omnicell Inc covered call is worth writing.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.

It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Income-focused investors, long-term OMCL holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling OMCL covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Omnicell Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryHealth Information Services
  • SectorHealthcare
  • IV percentile65.87% Neutral
  • Market cap (M$)1,545
  • 52 weeks high-38.42%
  • 52 weeks low16.55%
  • Analyst recommendationStrong Buy
    1.25
  • Target price$57.86
    71.74% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-10-29
  • P/E40.05
  • Future P/E16.21
  • EPS (ttm)0.85
  • EPS growth next 5 years14.94%

As of September 28, 2026

2026-11-205655.0063.400.100.802144.0063.70415.16-0.30+0.10160.70
2026-12-188440.0018.840.451.75679.0020.1787.65-1.34+0.27201.30
2026-11-205635.003.981.853.00319.009.4861.77-5.50+0.48281.15
2027-05-2123845.0033.690.504.401184.0035.1853.95-1.49+0.3303.90
2027-02-1914740.0018.840.503.80684.0020.3250.46-1.49+0.361013.30
2027-05-2123840.0018.841.756.00809.0024.0336.86-5.20+0.4504.25
2026-12-188435.003.981.504.90284.008.4436.66-4.46+0.5173.40
2027-02-1914735.003.983.006.10434.0012.8932.01-8.91+0.55213.10
2027-05-2123835.003.983.808.10514.0015.2723.42-11.29+0.5804.30

As of September 28, 2026

Sell covered calls with the data behind you

Find the best OMCL covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial